Basics Sagimet Biosciences Inc. Series A IPO Date: July 14, 2023 Sector: Healthcare Industry: Biotech Market Cap: $253.02M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 4.94% Avg Daily Range (30 D): $0.26 | 3.54% Avg Daily Range (90 D): $0.33 | 4.06% Institutional Daily Volume Avg Daily Volume: .75M Avg Daily Volume (30 D): .49M Avg Daily Volume (90 D): .72M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 87 Avg Trade Size (Sh.) (90 D): 102 Institutional Trades Total Inst.Trades: 63 Avg Inst. Trade: $1.32M Avg Inst. Trade (30 D): $.71M Avg Inst. Trade (90 D): $.78M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.51M Avg Closing Trade (30 D): $.88M Avg Closing Trade (90 D): $.83M Avg Closing Volume: 442.39K     News Oct 24, 2025 @ 11:00 AM Denifanstat Achieved All Endpoints in the Treatmen... Source: Sagimet Biosciences Sep 17, 2025 @ 11:00 AM Positive Phase 3 Results for Denifanstat for the T... Source: Sagimet Biosciences Inc. Sep 10, 2025 @ 11:00 AM Sagimet Biosciences Announces Upcoming Presentatio... Source: Sagimet Biosciences Aug 5, 2025 @ 11:00 AM Sagimet Biosciences to Participate in the Canaccor... Source: Sagimet Biosciences Jun 9, 2025 @ 11:00 AM Sagimet Biosciences to Host Virtual KOL Event, ââ... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.56 $-.5 $-1.45 Diluted EPS $-.56 $-.5 $-1.45 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -18.18M $ -16.2M $ -45.57M Operating Income / Loss $ -19.87M $ -18.2M $ -54.45M Cost of Revenue $ $ $ Net Cash Flow $ M $ -1.17M $ .7M PE Ratio